Vol 54, No 3 (2020)
Date published: 2020-06-30
Table of Contents
open access
paid access
Zbigniew K. Wszolek, Jarosław Sławek, Łukasz Stolarczyk
Editorial Note
Botulinum toxin for cervical dystonia: addressing treatment failure and improving outcomes
Ashley B. Pena
Invited Editorial
Massimo S. Fiandaca, Russell R. Lonser, J. Bradley Elder, Mirosław Ząbek, Krystof S. Bankiewicz
Invited Review Article
Cervical dystonia — improving the effectiveness of botulinum toxin therapy
Małgorzata Tyślerowicz, Weronika Kiedrzyńska, Bożena Adamkiewicz, Wolfgang H. Jost, Jarosław Sławek
Review Article
Smoking as a risk factor of onset and relapse of Multiple Sclerosis — a review
Patryk Jasielski, Faustyna Piędel, Agata Rocka, Véronique Petit, Konrad Rejdak
Review Article
Biomarkers in Multiple Sclerosis: a review of diagnostic and prognostic factors
Klaudia Sapko, Anna Jamroz-Wiśniewska, Michał Marciniec, Marcin Kulczyński, Anna Szczepańska-Szerej, Konrad Rejdak
Review Article
Fibrinogen concentrations in ischaemic stroke patients with metabolic disorders
Malgorzata Pawelczyk, Beata Kaczorowska, Zbigniew Baj
Research Paper
Late onset multiple sclerosis — multiparametric MRI characteristics
Łukasz Jasek, Janusz Śmigielski, Małgorzata Siger
Research Paper
Małgorzata Wiszniewska, Waldemar Fryze, Anna Wiśniewska, Michał Karliński, Piotr Sobolewski, Grzegorz Krzykowski, Anna Członkowska
Research Paper
Preferred muscles in cervical dystonia
Wolfgang H. Jost, Bo Biering-Sørensen, Artur Drużdż, Alexandre Kreisler, Sanjay Pandey, Jarosław Sławek, Laurent Tatu
Short Communication
Radiation therapy in patients with implanted deep brain stimulation
Michał J. Schinwelski, Jarosław Dulski, Wojciech Łuczak, Witold Libionka, Tomasz Mandat, Jarosław Sławek
Short Communication
Does amantadine have a protective effect against COVID-19?
Albert Cortés Borra
Letter to the Editors
Response to “Does amantadine have a protective effect against COVID-19?”
Philip W. Tipton, Zbigniew K. Wszolek
Response to Letter to the Editors